Pre-exposure Prophylaxis (PrEP) at Home
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aaron Siegler, PhD
Emory University
Principal Investigator - Kenneth Mayer, MD
Harvard Medical School (HMS and HSDM)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Emory University, Prism Health
Atlanta, Georgia, United States
- the Fenway Institute
Boston, Massachusetts, United States
- Open Arms Health Care Center
Jackson, Mississippi, United States
- Washington University Aids Clinical Trial Unit
St Louis, Missouri, United States
- Metrohealth
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Apr 2019
- Primary completion
- 15 Apr 2023
- Completion
- 15 Apr 2023
- Last update posted
- 26 Sept 2024
- Registered enrollment
- 318
- Registry id
- NCT03569813
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.